Surgery
Volume 147, Issue 3 , Pages 392-404 , March 2010

Survival benefit of liver transplantation and the effect of underlying liver disease

  • Ana L. Gleisner, MD

      Affiliations

    • Universidade Federal do Rio Grande do Sul, Rio Grande do Sul, Brazil
    • Department of Surgery, St. Louis University, St. Louis, MO
  • ,
  • Alvaro Muñoz, PhD

      Affiliations

    • Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Ajacio Brandao, MD

      Affiliations

    • Liver Transplantation Group, Complexo Hospitalar, Santa Casa, Porto Alegre, Rio Grande do Sul, Brazil
    • Department of Internal Medicine, Universidade Federal de Ciências da Saú de de Porto Alegre, Rio Grande do Sul, Brazil
  • ,
  • Claudio Marroni, MD

      Affiliations

    • Liver Transplantation Group, Complexo Hospitalar, Santa Casa, Porto Alegre, Rio Grande do Sul, Brazil
    • Department of Internal Medicine, Universidade Federal de Ciências da Saú de de Porto Alegre, Rio Grande do Sul, Brazil
  • ,
  • Maria Lucia Zanotelli, MD

      Affiliations

    • Department of Surgery, Universidade Federal de Ciências da Saú de de Porto Alegre, Rio Grande do Sul, Brazil
    • Liver Transplantation Group, Complexo Hospitalar, Santa Casa, Porto Alegre, Rio Grande do Sul, Brazil
  • ,
  • Guido Gracco Cantisani, MD

      Affiliations

    • Department of Surgery, Universidade Federal de Ciências da Saú de de Porto Alegre, Rio Grande do Sul, Brazil
    • Liver Transplantation Group, Complexo Hospitalar, Santa Casa, Porto Alegre, Rio Grande do Sul, Brazil
  • ,
  • Leila Beltrami Moreira, MD

      Affiliations

    • Department of Clinical Pharmacology, Universidade Federal de Ciências da Saú de de Porto Alegre, Rio Grande do Sul, Brazil
  • ,
  • Michael A. Choti, MD

      Affiliations

    • Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
  • ,
  • Timothy M. Pawlik, MD, MPH

      Affiliations

    • Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD
    • Corresponding Author InformationReprint requests: Timothy M. Pawlik, MD, MPH, Associate Professor of Surgery and Oncology, Department of Surgery, The Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 614, Baltimore, MD 21287

,Accepted 2 October 2009.

References 

  1. Walia A, Schumann R. The evolution of liver transplantation practices. Curr Opin Organ Transplant. 2008;13:275–279
  2. McKay D, Potter SR, Behrend T, Stella F, Steinberg S. Patients seeking alternatives to the long waiting list: a reality faced by transplant physicians. Prog Transplant. 2008;18:203–207
  3. Segev DL, Thompson RE, Locke JE, et al. Prolonged waiting times for liver transplantation in obese patients. Ann Surg. 2008;248:863–870
  4. Associação Brasileira de Transplante de Órgãos. São Paulo: Associação Brasileira de Transplante de Órgãos. Registro Brasileiro de Transplantes 2008 - Ano XIV n°2 (Jan a Dez). Accessed October 1, 2009: Available from URL: http://www.abto.org.br/abtov02/portugues/populacao/rbt/anoXIV_n2/index.aspx?idCategoria=2.
  5. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant. 2005;5:307–313
  6. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant?. Liver Transpl. 2004;10(10 Suppl. 2):S69–S73
  7. Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl. 2003;9:117–123
  8. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–1730
  9. UNOS policy 3.2. Organ Distribution: UNOS Patient Waiting List. Richmond, VA.: United Network for Organ Sharing, revised in 03/03/2009. Accessed October 1, 2009. Available from URL: http://www.unos.org.
  10. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–96
  11. Freeman RB, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851–858
  12. Brandao A, Fuchs SC, Gleisner AL, et al. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation. Clin Transplant. 2008;22:651–656
  13. Mauger EA, Wolfe RA, Port FK. Transient effects in the cox proportional hazards regression model. Stat Med. 1995;14:1553–1565
  14. Cox DR. Regression models and life tables. J Royal Stat Society Series. 1972;34:187–220
  15. Zaman MB, Hoti E, Qasim A, et al. MELD score as a prognostic model for listing acute liver failure patients for liver transplantation. Transplant Proc. 2006;38:2097–2098
  16. Child CG, Turcotte J. Surgery and portal hypertension. In:  Child CG editors. The liver and portal hypertension. Philadelphia: Saunders; 1964;p. 50–64
  17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  18. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int. 2004;24:1–8
  19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J. 1958;53:457–480
  20. Cox C, Chu H, Schneider MF, Munoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med. 2007;26:4352–4374
  21. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8:3–15
  22. Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken, NJ: Wiley-Interscience; 2004;
  23. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–790
  24. Rustgi VK. The epidemiology of hepatitis C infection in the United States. J Gastroenterol. 2007;42:513–521
  25. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008;8:419–425
  26. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA. 2004;291:1871–1874
  27. Schaffer RL, Kulkarni S, Harper A, Millis JM, Cronin DC. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl. 2003;9:1211–1215
  28. Santori G, Andorno E, Morelli N, et al. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center. Transplant Proc. 2008;40:1903–1905
  29. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data with application to prognostic modelling and estimation. Stat Med. 2002;15:2175–2197
  30. Putter H, Sasako M, Hartgrink HH, van de Velde CJ, van Houwelingen JC. Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial. Stat Med. 2005;24:2807–2821

 Dr Pawlik is supported by Grant Number 1KL2RR025006-01 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Dr Gleisner has been supported by a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society and by a grant from CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.

PII: S0039-6060(09)00616-3

doi: 10.1016/j.surg.2009.10.006

Surgery
Volume 147, Issue 3 , Pages 392-404 , March 2010